메뉴 건너뛰기




Volumn 2, Issue 2, 2004, Pages 127-139

Humoral immunity in HIV-1 exposure: Cause or effect of HIV resistance?

Author keywords

ESN; HIV; Humoral immunity; LTNP; Mucosal immunity; Neutralising antibodies; Resistance

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; DEFENSIN; DNA VACCINE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G; INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY B12; OKT 8; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

EID: 3042720288     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570162043484951     Document Type: Review
Times cited : (20)

References (187)
  • 4
    • 0042127158 scopus 로고    scopus 로고
    • Anonymus
    • Anonymus. (2003) Drugs R D 4:249-253.
    • (2003) Drugs R. D. , vol.4 , pp. 249-253
  • 83
    • 0037472477 scopus 로고    scopus 로고
    • Klein M. (2003) Vaccine 21:616-619.
    • (2003) Vaccine , vol.21 , pp. 616-619
    • Klein, M.1
  • 88
    • 0038325754 scopus 로고    scopus 로고
    • Lehner T. (2003) Vaccine 21 Suppl 2:S68-S76.
    • (2003) Vaccine , vol.21 , Issue.SUPPL. 2
    • Lehner, T.1
  • 165
  • 178
    • 1642330378 scopus 로고    scopus 로고
    • WHO. access in December 2003
    • WHO. AIDS Epidemic Update (2002); access in December 2003.
    • (2002) AIDS Epidemic Update


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.